179 related articles for article (PubMed ID: 17987287)
1. Glycosylation of prothrombin fragment 1 governs calcium oxalate crystal nucleation and aggregation, but not crystal growth.
Webber D; Rodgers AL; Sturrock ED
Urol Res; 2007 Dec; 35(6):277-85. PubMed ID: 17987287
[TBL] [Abstract][Full Text] [Related]
2. Sialylation of urinary prothrombin fragment 1 is implicated as a contributory factor in the risk of calcium oxalate kidney stone formation.
Webber D; Radcliffe CM; Royle L; Tobiasen G; Merry AH; Rodgers AL; Sturrock ED; Wormald MR; Harvey DJ; Dwek RA; Rudd PM
FEBS J; 2006 Jul; 273(13):3024-37. PubMed ID: 16817853
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of growth and aggregation of calcium oxalate crystals in vitro--a comparison of four human proteins.
Grover PK; Moritz RL; Simpson RJ; Ryall RL
Eur J Biochem; 1998 May; 253(3):637-44. PubMed ID: 9654060
[TBL] [Abstract][Full Text] [Related]
4. Face-specific binding of prothrombin fragment 1 and human serum albumin to inorganic and urinary calcium oxalate monohydrate crystals.
Cook AF; Grover PK; Ryall RL
BJU Int; 2009 Mar; 103(6):826-35. PubMed ID: 19021614
[TBL] [Abstract][Full Text] [Related]
5. Effect of prothrombin and its activation fragments on calcium oxalate crystal growth and aggregation in undiluted human urine in vitro: relationship between protein structure and inhibitory activity.
Grover PK; Ryall RL
Clin Sci (Lond); 2002 Apr; 102(4):425-34. PubMed ID: 11914105
[TBL] [Abstract][Full Text] [Related]
6. Intracrystalline proteins and urolithiasis: a comparison of the protein content and ultrastructure of urinary calcium oxalate monohydrate and dihydrate crystals.
Ryall RL; Chauvet MC; Grover PK
BJU Int; 2005 Sep; 96(4):654-63. PubMed ID: 16104927
[TBL] [Abstract][Full Text] [Related]
7. Calcium phosphate crystal-associated proteins: alpha-2-HS-glycoprotein, prothrombin fragment 1 and osteopontin.
Nishio S; Hatanaka M; Takeda H; Aoki K; Iseda T; Iwata H; Yokoyama M
Int J Urol; 2001 Aug; 8(8):S58-62. PubMed ID: 11555022
[TBL] [Abstract][Full Text] [Related]
8. The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro.
Ryall RL; Grover PK; Stapleton AM; Barrell DK; Tang Y; Moritz RL; Simpson RJ
Clin Sci (Lond); 1995 Nov; 89(5):533-41. PubMed ID: 8549069
[TBL] [Abstract][Full Text] [Related]
9. Nucleation of calcium oxalate crystals by albumin: involvement in the prevention of stone formation.
Cerini C; Geider S; Dussol B; Hennequin C; Daudon M; Veesler S; Nitsche S; Boistelle R; Berthézène P; Dupuy P; Vazi A; Berland Y; Dagorn JC; Verdier JM
Kidney Int; 1999 May; 55(5):1776-86. PubMed ID: 10231440
[TBL] [Abstract][Full Text] [Related]
10. Effects of urinary prothrombin fragment 1 in the formation of calcium oxalate calculus.
Liu J; Chen J; Wang T; Wang S; Ye Z
J Urol; 2005 Jan; 173(1):113-6. PubMed ID: 15592049
[TBL] [Abstract][Full Text] [Related]
11. Calcium phosphate crystal-associated proteins: alpha2-HS-glycoprotein, prothrombin F1, and osteopontin.
Nishio S; Hatanaka M; Takeda H; Aoki K; Iseda T; Iwata H; Yokoyama M
Mol Urol; 2000; 4(4):383-90. PubMed ID: 11156706
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of calcium oxalate crystal growth and aggregation by prothrombin and its fragments in vitro: relationship between protein structure and inhibitory activity.
Grover PK; Ryall RL
Eur J Biochem; 1999 Jul; 263(1):50-6. PubMed ID: 10429186
[TBL] [Abstract][Full Text] [Related]
13. The effect of warfarin therapy on the charge properties of urinary prothrombin fragment 1 and crystallization of calcium oxalate in undiluted human urine.
Buchholz NP; Kim DS; Grover PK; Dawson CJ; Ryall RL
J Bone Miner Res; 1999 Jun; 14(6):1003-12. PubMed ID: 10352110
[TBL] [Abstract][Full Text] [Related]
14. Glycoprotein calcium oxalate crystal growth inhibitor in urine.
Worcester EM; Nakagawa Y; Coe FL
Miner Electrolyte Metab; 1987; 13(4):267-72. PubMed ID: 3306319
[TBL] [Abstract][Full Text] [Related]
15. Uric acid-binding proteins in calcium oxalate stone formers and their effect on calcium oxalate crystallization.
Kalaiselvi P; Udayapriya KL; Selvam R
BJU Int; 1999 Jun; 83(9):919-23. PubMed ID: 10368229
[TBL] [Abstract][Full Text] [Related]
16. Crystallization properties in urine from calcium oxalate stone formers.
Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of stone formation.
Worcester EM
Semin Nephrol; 1996 Sep; 16(5):474-86. PubMed ID: 8890402
[TBL] [Abstract][Full Text] [Related]
18. Urinary calcium oxalate crystal growth inhibitors.
Worcester EM
J Am Soc Nephrol; 1994 Nov; 5(5 Suppl 1):S46-53. PubMed ID: 7873744
[TBL] [Abstract][Full Text] [Related]
19. Synergism between urinary prothrombin fragment 1 and urine: a comparison of inhibitory activities in stone-prone and stone-free population groups.
Webber D; Rodgers AL; Sturrock ED
Clin Chem Lab Med; 2002 Sep; 40(9):930-6. PubMed ID: 12435111
[TBL] [Abstract][Full Text] [Related]
20. The hole truth: intracrystalline proteins and calcium oxalate kidney stones.
Ryall RL; Fleming DE; Grover PK; Chauvet M; Dean CJ; Marshall VR
Mol Urol; 2000; 4(4):391-402. PubMed ID: 11156707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
